What is happening
Oakley Capital is weighing an exit from Phenna Group, a company in the testing and certification space, according to people with knowledge of the discussions who requested anonymity because the matter is private. The private equity owner has brought in Goldman Sachs Group Inc. to help evaluate a possible sale.
What Phenna does and financials
Per the company's website, Phenna works across testing, inspection, certification and compliance, serving areas such as infrastructure, industrial markets, food, and life sciences. Some of the people familiar with the business put annual earnings at about £250 million, or $333 million.
Ownership backdrop and timing
Oakley invested in Phenna in 2022 for an undisclosed amount. A sale could take place in 2027, though the process is in its early days and Oakley could opt to retain the asset. Representatives indicated that both Oakley and Goldman Sachs had no comment when asked.
Major corporate moves remind investors that timely information can shape smarter decisions. We're hosting our first ever investor livestream on 11/17 to show you how to use ChatGPT and Claude to invest like a pro, hosted by Briefs Finance CEO Jaspreet Singh. Save your seat.
Why it matters for your portfolio
If a 2027 sale proceeds, it sets a clock for a sizable sponsor exit in testing and compliance, a steady, regulation-driven niche. The bottom line: watch for read-throughs to valuation expectations in private markets and to public comps in quality assurance, where deal chatter can reset multiples.
Using new tools thoughtfully helps investors uncover subtle opportunities and reduce guesswork. On 11/17, our CEO Jaspreet Singh goes live for our first ever investor livestream on how to use ChatGPT and Claude to invest like a pro. Register to join him.
